Mutations in the Human Laminin beta 2 (LAMB2) Gene and the Associated Phenotypic Spectrum
Date
2010Author
Bockenhauer, Detlef
Annexstad, Ellen
Barrow, Margaret
Blahova, Kveta
Cheong, Hae Il
Maruniak-Chudek, Iwona
Cochat, Pierre
Doetsch, Joerg
Gajjar, Priya
Hennekam, Raoul C.
Janssen, Francoise
Kagan, Mikhail
Kariminejad, Ariana
Kemper, Markus J.
Koenig, Jens
Kogan, Jillene
Kroes, Hester Y.
Kuwertz-Broeking, Eberhard
Lewanda, Amy F.
Medeira, Ana
Muscheites, Jutta
Niaudet, Patrick
Pierson, Michel
Saggar, Anand
Seaver, Laurie
Suri, Mohnish
Tsygin, Alexey
Wuehl, Elke
Zurowska, Aleksandra
Uebe, Steffen
Hildebrandt, Friedhelm
Antignac, Corinne
Zenker, Martin
Aytac, Mehmet B.
Matejas, Verena
Hinkes, Bernward
Alkandari, Faisal
Al-Gazali, Lihadh
Metadata
Show full item recordAbstract
Mutations of LAMB2 typically cause autosomal recessive Pierson syndrome, a disorder characterized by congenital nephrotic syndrome, ocular and neurologic abnormalities, but may occasionally be associated with milder or oligosymptomatic disease variants. LAMB2 encodes the basement membrane protein laminin beta 2, which is incorporated in specific heterotrimeric laminin isoforms and has an expression pattern corresponding to the pattern of organ manifestations in Pierson syndrome. Herein we review all previously reported and several novel LAMB2 mutations in relation to the associated phenotype in patients from 39 unrelated families. The majority of disease-causing LAMB2 mutations are truncating, consistent with the hypothesis that loss of laminin beta 2 function is the molecular basis of Pierson syndrome. Although truncating mutations are distributed across the entire gene, missense mutations are clearly clustered in the N-terminal LN domain, which is important for inter-molecular interactions. There is an association of missense mutations and small in frame deletions with a higher mean age at onset of renal disease and with absence of neurologic abnormalities, thus suggesting that at least some of these may represent hypomorphic alleles. Nevertheless, genotype alone does not appear to explain the full range of clinical variability, and therefore hitherto unidentified modifiers are likely to exist. Hum Mutat 31:992-1002, 2010. (c) 2010 Wiley-Liss, Inc.
Collections
- Makale [92796]